ReWalk Robotics (RWLK) Misses Q4 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
ReWalk Robotics Reports Fourth Quarter and Full Year 2022 Financial Results
February 23, 2023 8:00 AM ESTStrong Conclusion to 2022 Q422 Revenue Highest Since Start of COVID-19 Pandemic
Record Quarterly MyoCycle Sales Supplement Improved Exoskeleton Revenue  Â
MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Feb. 23, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (ReWalk or the Company), a medical device company that designs, develops, and commercializes innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, today announced its financial... More



